Comment from Lupus Foundation of America
AnonymousSupportAdvocacy
Summary: The Lupus Foundation of America supports the FDA's initiative to document the impacts of Patient-Focused Drug Development (PFDD) meetings. The organization provides detailed examples of how a past lupus PFDD meeting influenced research priorities, advocacy strategies, clinical practice, and healthcare decision-making.
See attached file(s)